GB0722087D0 - Polyamides - Google Patents

Polyamides

Info

Publication number
GB0722087D0
GB0722087D0 GBGB0722087.4A GB0722087A GB0722087D0 GB 0722087 D0 GB0722087 D0 GB 0722087D0 GB 0722087 A GB0722087 A GB 0722087A GB 0722087 D0 GB0722087 D0 GB 0722087D0
Authority
GB
United Kingdom
Prior art keywords
polyamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0722087.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Products UK Ltd
Original Assignee
ADC Products UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Products UK Ltd filed Critical ADC Products UK Ltd
Priority to GBGB0722087.4A priority Critical patent/GB0722087D0/en
Publication of GB0722087D0 publication Critical patent/GB0722087D0/en
Priority to PCT/GB2008/003767 priority patent/WO2009060215A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0722087.4A 2007-11-09 2007-11-09 Polyamides Ceased GB0722087D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0722087.4A GB0722087D0 (en) 2007-11-09 2007-11-09 Polyamides
PCT/GB2008/003767 WO2009060215A1 (fr) 2007-11-09 2008-11-07 Polyamides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0722087.4A GB0722087D0 (en) 2007-11-09 2007-11-09 Polyamides

Publications (1)

Publication Number Publication Date
GB0722087D0 true GB0722087D0 (en) 2007-12-19

Family

ID=38858489

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0722087.4A Ceased GB0722087D0 (en) 2007-11-09 2007-11-09 Polyamides

Country Status (2)

Country Link
GB (1) GB0722087D0 (fr)
WO (1) WO2009060215A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
KR101671360B1 (ko) 2010-04-15 2016-11-01 시애틀 지네틱스, 인크. 표적화된 피롤로벤조디아제핀 접합체
WO2011130616A1 (fr) 2010-04-15 2011-10-20 Spirogen Limited Pyrrolobenzodiazépines utilisées pour traiter des maladies prolifératives
CN103987718A (zh) 2011-09-20 2014-08-13 斯皮罗根有限公司 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓
EP3388435B1 (fr) 2011-10-14 2023-05-03 Seagen Inc. Pyrrolobenzodiazépines et conjugués ciblés
EA028457B1 (ru) 2011-10-14 2017-11-30 Медимьюн Лимитед Пирролобензодиазепины
BR112014008981A2 (pt) 2011-10-14 2017-05-02 Spirogen Sàrl pirrolobenzodiazepinas
EA036202B1 (ru) 2011-10-14 2020-10-14 Сиэтл Дженетикс, Инк. Пирролбензодиазепины и конъюгаты направленного действия
WO2014057072A1 (fr) 2012-10-12 2014-04-17 Spirogen Sàrl Synthèse et intermédiaires de dérivés de pyrrolobenzodiazépine pour conjugaison
NZ705910A (en) 2012-10-12 2018-09-28 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
AU2013328580B2 (en) 2012-10-12 2016-01-21 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
EP2935268B2 (fr) 2012-12-21 2021-02-17 MedImmune Limited Pyrrolobenzodiazépines et conjugués associés
CN105246894A (zh) 2012-12-21 2016-01-13 斯皮罗根有限公司 用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
NZ710745A (en) 2013-03-13 2019-03-29 Genentech Inc Pyrrolobenzodiazepines and conjugates thereof
US9649390B2 (en) 2013-03-13 2017-05-16 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
CA3047683C (fr) 2017-02-08 2020-03-10 Adc Therapeutics Sa Conjugues anticorps-pyrrolobenzodiazepine
LT3612537T (lt) 2017-04-18 2022-10-10 Medimmune Limited Pirolobenzodiazepino konjugatai
LT3668874T (lt) 2017-08-18 2022-03-25 Medimmune Limited Pirolobenzodiazepino konjugatai
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
US20230092441A1 (en) * 2019-12-24 2023-03-23 The Regents Of The University Of California Compositions and methods for treating cancer and improving epithelial homeostasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513759A (ja) * 1996-02-26 2001-09-04 カリフォルニア・インスティチュート・オブ・テクノロジー 二本鎖ｄｎａの副溝において結合する改良されたポリアミド
GB0404574D0 (en) * 2004-03-01 2004-04-07 Spirogen Ltd Amino acids
WO2005087762A1 (fr) * 2004-03-13 2005-09-22 Tmrc Co., Ltd. Nouveau dérivé indole servant à alkyler une sequence de bases spécifique d'adn et agent alkylant et médicament comprenant chacun celui-ci

Also Published As

Publication number Publication date
WO2009060215A1 (fr) 2009-05-14

Similar Documents

Publication Publication Date Title
GB0722087D0 (en) Polyamides
EP2180018A4 (fr) Composition de polyamide
EP2212908A4 (fr) Transistor à effet de champ à jonction à ailette
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (fr) Spiroindalones
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (fr) Biopulpe
EP2235089A4 (fr) Polyamides
EP1999184A4 (fr) Polyamides
GB0701437D0 (en) Electro-chlorinator
GB0705247D0 (en) P1242
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0700595D0 (en) Holecutter
AU3642P (en) TAS100 Dianella tasmanica
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3702P (en) DarwinGold Dianella ensifolia
AU3646P (en) TAS300 Dianella tasmanica
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3606P (en) Jaywick xTriticosecale
GB0707990D0 (en) V j scope
GB0724415D0 (en) CV-kinisis II
GB0714068D0 (en) No riveal
GB0713975D0 (en) No Riveal
GB0720259D0 (en) Eletrcity meeting improvements
AU2007250V (en) Calgreen1GL Calothamnus quadrifidus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)